News of recent FDA drug approvals and orphan drug designations for humans and animals.
Data collected as of September 2021.
Tivdak
tisotumab vedotin-tftv
SEAGEN
9/20/2021
To treat recurrent or metastatic cervical cancer with disease progression on or after chemotherapy
Exkivity
mobocertinib
Takeda
9/15/2021
To treat locally advanced or metastatic non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations.
Learn MoreNovel Drug Approvals for 2021
VETERINARY MEDICINE
Original Approvals
Tanovea
Rabacfosadine
VetDC Inc.
July 15, 2021
For treatment of lymphoma in dogs.
Carponfen Tablets
Carprofen
Dechra Veterinary Products LLC
July 7, 2021
For pain relief associated with osteoarthritis in dogs.
Learn MoreApproved Animal Drug Products
Merck’s Covid Antiviral Gets WHO Backing for High-Risk Patients
Mental-Health Scars Stay With Survivors Long After Covid Battle
Biden Says Easing of Mask Rules by Governors Is ‘a Tough Call’
Is Covid Becoming Endemic? What Would That Mean?: QuickTake
To read the full content, please log in with your AAPS member username and password.
Sign InNot a member? Learn more and join today!
Contact Us:
Kristen Kalmann, Content Manager 2107 Wilson Blvd. Ste. 200 Arlington, VA 22201
Advertising
Kira Krewson1-770-810-6982 View the Media Kit
AAPS Customer Service
1-703-243-2800